Sun Pharma Q1 preview: Weak Taro show, soft US sales to weigh on earnings
Consolidated net profit is seen declining 1.4% YoY to Rs 2,033 crore. India’s largest pharmaceutical company by market capitalization is scheduled to release its earnings on Thursday.
